APOL1-Mediated Kidney Disease (AMKD)Symptoms, Doctors, Treatments, Advances & More
Learn About APOL1-Mediated Kidney Disease (AMKD)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Bowdoin Street Health Center
Martin Pollak is a primary care provider, practicing in Internal Medicine in Dorchester, Massachusetts. Dr. Pollak is rated as an Elite provider by MediFind in the treatment of APOL1-Mediated Kidney Disease (AMKD). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Focal Segmental Glomerulosclerosis, APOL1-Mediated Kidney Disease (AMKD), Glomerulonephritis, Nephrotic Syndrome, and Kidney Transplant. Dr. Pollak is board certified in American Board Of Internal Medicine. Dr. Pollak is currently accepting new patients.
Yadkin Dialysis Center
Barry Freedman is a Nephrologist practicing medicine in Yadkinville, North Carolina. Dr. Freedman is rated as an Elite provider by MediFind in the treatment of APOL1-Mediated Kidney Disease (AMKD). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses APOL1-Mediated Kidney Disease (AMKD), Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy. Dr. Freedman is currently accepting new patients.
Conejo Free Clinic
Ogo Egbuna is a Nephrologist practicing medicine in Thousand Oaks, California. Dr. Egbuna is rated as an Elite provider by MediFind in the treatment of APOL1-Mediated Kidney Disease (AMKD). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses APOL1-Mediated Kidney Disease (AMKD), Chronic Kidney Disease, IgA Nephropathy, Glomerulonephritis, and Kidney Transplant.
Summary: The Duke ApoL1 Nephropathy Biorepository aims to address needs within non-diabetic kidney failure research by utilizing existing and, when necessary, developing new infrastructure to support the consent of patients and the collection of dedicated samples for ApoL1 Nephropathy biorepository. The mutations in ApoL1 gene that are strongly associated with kidney disease are only present in individuals...
Summary: Clinical Performance Study SP2024001, is a prospective, interventional study to assess the clinical performance of the APOL1 Genotyping Clinical Trial Assay (CTA) in the intended use population and environment. The study will use the APOL1 Genotyping CTA to test deoxyribonucleic acid (DNA) extracted from blood specimens to identify individuals who are homozygous or compound heterozygous for apolip...